Source: Eur Respir J 2004; 23: 255-262
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Heitmann J., Ehlenz K., Penzel T., Becker H.F., Grote L., Voigt K.H., Hermann Peter J., Vogelmeier C.. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-262

Member's Comments

No comment yet.

Related content which might interest you: Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep Source: Eur Respir Rev 2007; 16: 115-124 Year: 2007 Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP Source: Eur Respir J 2006; 27: 128-135 Year: 2006 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 CPAP and measures of cardiovascular risk in males with OSAS Source: Eur Respir J 2008; 32: 1488-1496 Year: 2008 Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 294s Year: 2006 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Serotonin in obstructive sleep apnea patients with before and after the continuous positive airway pressure treatment Source: Annual Congress 2005 - Upper airway interventions in OSA patients Year: 2005 Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients Source: Eur Respir J 2009; 34: 694 Year: 2009 Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea Source: Eur Respir J 2013; 42: 863-866 Year: 2013 Efficacy of an automatic positive airway pressure system for treatment of obstructive sleep apnoea Source: Eur Respir J 2002; 20: Suppl. 38, 9s Year: 2002 Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke Source: Eur Respir J 2001; 18: 623-629 Year: 2001 Blood pressure responsiveness to obstructive events during sleep after chronic CPAP Source: Eur Respir J 2003; 21: 509-514 Year: 2003 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Long-term continuous positive airway pressure compliance in females with obstructive sleep apnoea Source: Eur Respir J 2013; 42: 1255-1262 Year: 2013